Company / Revenue
Envista Holdings Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.7B
FY2025
5-year range
$2.5B / $2.7B
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#67 of 150
Health Care
What the data says
At $2.7B, Envista Holdings's revenue ranks #67 of 150 in the Health Care sector. Revenue returned to growth in FY2025 after 2 years of decline, reaching $2.7B.
Based on SEC 10-K filings.
$2.7B in FY2025 with a 5-year CAGR of +7.1%.
Improved from $2.6B to $2.7B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
#67 of 150 in Health CareTop 45% of 150This company $2.7B Sector average $19.5B
▼
-86.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.1%, indicating consistent growth.
- In FY2025, revenue increased 8.3% year-over-year.
- Ranks #67 out of 150 companies in the Health Care sector.
- Peak revenue was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7B | +8.3% |
| FY2024 | $2.5B | -2.2% |
| FY2023 | $2.6B | -0.1% |
| FY2022 | $2.6B | +2.4% |
| FY2021 | $2.5B | +30.1% |
| FY2020 | $1.9B | -15.6% |
| FY2019 | $2.3B | -19.7% |
| FY2018 | $2.8B | +1.2% |
| FY2017 | $2.8B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026